Effect of Ankle Joint Manipulation on Chronic Ankle Sprain With Compressed Ankle Joint for Volleyball and Basketball Players
The goal of this pre-post randomized controlled experimental trial is to examine the impact of ankle joint manipulation on chronic ankle sprain with a compressed ankle joint in athletes (identified in the proposal as volleyball, basketball, and tennis players) aged 16 to 45 years of both genders.
The main questions it aims to answer are:
Does ankle joint manipulation effectively reduce pain and improve functional status? Does the treatment successfully increase ankle range of motion (ROM)?
Researchers will compare an experimental group receiving manipulation to a control group receiving no treatment to determine the intervention's effectiveness.
Participants will:
- Be randomly assigned into two equal groups of 30 patients each.
- Either receive a one-shot manipulation of the head of the fibula or receive no treatment.
- Have their ankle range of motion measured using an electronic goniometer.
- Report their ankle pain levels measured by a numeric analog scale.
- Complete a functional assessment evaluated by the ankle joint functional index.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yasmein Mohammed Mahmoud, PhD.
- Phone Number: 01061344240
- Email: yasmeinyossef@gmail.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Participants must be volleyball, basketball, or tennis players. Participants must have a chronic ankle sprain with a compressed ankle joint. Participants must be within the age range of 16 to 45 years. Participants can be of either gender. Participants must be willing to sign a consent form according to the Helsinki Protocol.
Exclusion Criteria:
- History of acute severe ankle fractures or previous lower extremity surgeries.
- Presence of open wounds, skin lesions, or severe dermatological conditions around the ankle or fibula region that contraindicate manual manipulation.
- Acute systemic inflammatory conditions or arthropathies (such as rheumatoid arthritis or gout).
- Neurological deficits, severe peripheral neuropathy, or vascular disorders affecting the lower limbs.
- Receipt of any other physical therapy treatments, injections, or interventions for the ankle within the weeks preceding the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control Group
|
|
|
Experimental: Head of Fibula Manipulation
|
The intervention consists of a single session ("one shoot") manual manipulation targeting the head of the fibula. This manipulation targets joint compression, often addressing posterior positional faults of the talus, to restore normal arthrokinematics. The procedure is intended to instantly improve dorsiflexion range of motion, reduce anterior impingement pain, and enhance dynamic balance and landing mechanics in athletes. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ankle range of motion measured by an electronic goniometer
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ankle pain measured by a numeric analog scale
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
|
Ankle function assessed by the ankle joint functional index
Time Frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Mohammed Abdelaziz Emam, master degree, Ass.lecturer, faculty of physical therapy, kafr elshiekh university
- Principal Investigator: Reda Fathi Elbosaty, Bachelor student, faculty of physical therapy, kafr elshiekh university
- Principal Investigator: Yasmein Mohammed Mahmoud, Ph.D, lecturer, faculty of physical therapy, kafr elshiekh university
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- KFSIRB200-1212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Data will be shared upon reasonable request from the principal investigator.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.